This bill amends Alaska's insurance laws to require health care insurers to provide coverage for the prophylaxis, diagnosis, and treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome. The coverage mandated includes various treatment options such as antimicrobials, medication, behavioral therapies, immunomodulating medicines, plasma exchange, and intravenous immunoglobulin therapy. Insurers are prohibited from denying or delaying coverage based on previous treatments, diagnostic names, or age, and they cannot impose restrictions that are inconsistent with established treatment guidelines.

Additionally, the bill specifies that coverage for these disorders must not be more restrictive than coverage for other illnesses and allows insurers to request treatment notes and other information to determine medical necessity, provided that such determinations are made consistently with other covered conditions. The bill defines key terms related to the disorders and establishes an effective date of January 1, 2027, for the new coverage requirements.

Statutes affected:
HB0292A, AM HB 292, introduced 02/04/2026: